| Olivia Christine Wolever, PA-C | |
|
92 N High St Ste 260, Dublin, OH 43017-1195 | |
| (614) 442-7610 | |
| Not Available |
| Full Name | Olivia Christine Wolever |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 92 N High St Ste 260, Dublin, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487353777 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.008054RX (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olivia Christine Wolever, PA-C 586 Arden St, Lewis Center, OH 43035-8441 Ph: (614) 670-6172 | Olivia Christine Wolever, PA-C 92 N High St Ste 260, Dublin, OH 43017-1195 Ph: (614) 442-7610 |
News Archive
Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.
A low-cost device that Rice University bioengineering students invented to help premature babies breathe more easily will be rolled out to teaching hospitals in three African nations, thanks to a $400,000 award from pharmaceutical giant GlaxoSmithKline and London-based charity Save the Children. The technology, which is known as "bubble CPAP," earned the top prize in GSK and Save the Children's inaugural Healthcare Innovation Award program.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
Nektar Therapeutics today announced positive data from a Phase 1 clinical study of NKTR-181 evaluating multiple ascending oral doses of NKTR-181 over an 8-day treatment period in healthy subjects.
Over 20 million people in Europe suffer from osteoarthritis which can lead to extensive damage to the knee and hip cartilage. Stem cells offer a promising way forward but a key challenge has been to design a 'smart material' that is biologically effective for cartilage tissue regeneration. Now researchers have identified a blend of naturally occurring fibres such as cellulose and silk that makes progress towards affordable and effective cell-based therapy for cartilage repair a step closer
› Verified 9 days ago
Ryan Rushen, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 7500 Hospital Dr, Dublin, OH 43016 Phone: 614-544-8000 | |
Amy L Nutting, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 650 Shawan Falls Dr, Dublin, OH 43017 Phone: 614-764-1711 Fax: 614-889-2652 | |
Emily Ballinger, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7450 Hospital Dr Ste 290, Dublin, OH 43016 Phone: 145-448-1116 Fax: 614-544-8109 | |
Jeffrey William Blitz, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7698 Scioto Crossing Blvd, Dublin, OH 43016 Phone: 614-634-1881 | |
Laura Kessler, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6905 Hospital Dr, Ste 200, Dublin, OH 43016 Phone: 614-544-8150 Fax: 614-544-8151 | |
Mrs. Sarah A. Landis, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 650 Shawan Falls Dr, Dublin, OH 43017 Phone: 614-764-1711 Fax: 614-889-2652 | |
Jeffrey Robert Fisher, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6905 Hospital Dr, Suite 130, Dublin, OH 43016 Phone: 614-923-0300 Fax: 614-923-0400 |